Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. Its Healthcare Services include service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology. It serves corporate, individuals, and public payers. Medicover AB (publ) was founded in 1995 and is headquartered in Stockholm, Sweden.
Metrics to compare | MCOVBs | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMCOVBsPeersSector | |
---|---|---|---|---|
P/E Ratio | 84.5x | 20.1x | −0.5x | |
PEG Ratio | 0.97 | 0.37 | 0.00 | |
Price/Book | 7.8x | 2.3x | 2.6x | |
Price / LTM Sales | 1.6x | 0.7x | 3.3x | |
Upside (Analyst Target) | - | 30.1% | 42.8% | |
Fair Value Upside | Unlock | 22.8% | 6.5% | Unlock |